Most of the risk factors for keratitis are easily modifiable. Medscape Ophthalmology
Category: News
Are Branded and Generic Drugs Really the Same?
A survey of over 1400 Medscape physicians, nurse practitioners, and physician assistants describes prescribers’ experiences with use of generic agents. Medscape Pharmacists
Recommended Vaccines for All Healthcare Personnel
Everyone who ‘shares air’ with patients needs these vaccines. CDC Expert Commentary
Light-Sensitive Moiety Added To Anesthetic Propofol Allowing Control Of Narcotic Effect By Light – May Treat Certain Eye Diseases
In a new study, a light-sensitive moiety has been added to propofol, a commonly used anesthetic, allowing its narcotic effect to be controlled by light. The compound also offers a possible route to the treatment of certain eye diseases. Inhibitory neu…
Fifth Military Vision Research Symposium to take place from Sept. 18-20
Eye injuries in war have changed – and increased in number – as weapons, tactics, technology and strategies have evolved. Today’s soldiers face threats from explosive devices that cause extensive damage areas not protected by body armor. Military exper…
University of Rochester faculty member to receive Ant-nio Champalimaud Vision Award
David Williams, a faculty member of the University of Rochester’s Institute of Optics, director of its Center for Visual Science, and dean for research in Arts, Science, and Engineering, will receive the Ant-nio Champalimaud Vision Award at a ceremony …
‘Real World’ Trial of Ranibizumab Raises No Safety Signals
A large trial confirms the efficacy and safety of ranibizumab for wet age-related macular degeneration in the clinical practice setting. Medscape Medical News
Factors predictive of successful DME treatment revealed
The pretreatment central subfield thickness in the eyes of patients with diabetic macular edema is the strongest predictor of outcome after one year of treatment with ranibizumab, with a reduction linked to better visual acuity outcomes, report researc…
Imagine Eyes rtx1 Retinal Camera Delivers Cellular Resolution
Imagine Eyes, a company based in Orsay, France, is making available its rtx1 Adaptive Optics Retinal Camera to ophthalmologists in Europe now that it’s CE Marked. The imaging system allows visualization of the retina at cellular scale, resolving …
Corneal Surface Changes After Q-Value Guided LASIK and LASEK
How do visual acuity, corneal high-order aberrations, and changes in the anterior corneal surface compare between Q-value guided LASIK and LASEK? This new study looks at the two procedures. BMC Ophthalmology
Automatic 2% Medicare Cut Will Cost 767,000 Jobs, Study Says
Most of the lost jobs are outside healthcare. Organized medicine is urging Congress to spare physicians the consequences of ‘sequestration,’ scheduled for next year. Medscape Medical News
Readily available index provides practical landmarks for glaucoma patients
The mean deviation index, a widely understood metric for summarizing damage to an individuals’ visual field, could help physicians estimate practical landmarks in patients with glaucoma such as fitness to drive, report UK researchers.
12th EURETINA Congress
Read clinically focused news coverage of key developments from EURETINA 2012. Medscape Ophthalmology
Bioengineers design nanoparticles that can safely and predictably infiltrate deep into the brain
The brain is a notoriously difficult organ to treat, but Johns Hopkins researchers report they are one step closer to having a drug-delivery system flexible enough to overcome some key challenges posed by brain cancer and perhaps other maladies affecti…
GEN Reports On Ocular Therapeutics Targeting The Retina
Therapies for retinal diseases are expected to overtake those for glaucoma by 2014, reports Genetic Engineering & Biotechnology News (GEN). Because current retinal disease treatments only improve vision for six to eight weeks, there is a critical need…
Joslin Diabetes Center, Mass. Eye and Ear partner to form clinical and research alliance
Massachusetts Eye and Ear and the Joslin Diabetes Center announced today that they have reached agreement to form a clinical and research alliance, aimed toward providing coordinated high quality care to eye patients throughout greater Boston, especial…
Phase III data for Suvorexant, an investigational insomnia medicine, announced
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. The new data are from one of the longest, continuously-dosed…
UC Irvine receives CIRM grant to advance stem cell-based treatments for AD, retinitis pigmentosa
Efforts to begin human clinical trials using stem cells to treat Alzheimer’s disease and retinitis pigmentosa received a $37.3 million boost from the California Institute for Regenerative Medicine during its most recent round of funding on Sept. 5.
Effects of Caffeinated Coffee Consumption on Glaucoma
Does caffeine consumption cause intraocular pressure to rise and, if so, what is the risk for patients with or at risk for glaucoma? Eye
20/20–Alcohol and Age-Related Macular Degeneration
Is there an association between moderate alcohol use and age-related macular degeneration? American Journal of Epidemiology